Company Information & Drug Savings for Adamas Pharmaceuticals Medications

Adamas Pharmaceuticals is a specialty pharmaceutical company focused on developing treatments for chronic neurological diseases. Based in Emeryville, California, Adamas created Gocovri (amantadine extended-release), the first and only FDA-approved treatment for dyskinesia in Parkinson’s disease patients taking levodopa. The company’s expertise includes CNS drug development, movement disorders, and neurodegenerative disease therapies.

Adamas Pharmaceuticals

How to Contact Adamas Pharmaceuticals

Browse Medications Manufactured by Adamas Pharmaceuticals

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch